Figure 1.
Ten-year OS after start of HU and RUXO in PS-matched groups. Kaplan-Meier survival curves according to time after diagnosis to first administration of RUXO (red solid line) or HU (blue dotted line). The number of patients at risk is plotted every year. P-values were calculated by log-rank test.